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Introduction: This is the first study conducted in Wales, UK to evaluate the usefulness of a 
lifestyle prescription form (L℞) for use by prescribing clinicians in both the primary and 
secondary health care settings in the Cwm Taf University Health Board, Wales, UK and to 
gauge clinician opinion on the use of such a novel material tool. 
Objective: To establish the views of clinicians on the feasibility and effectiveness of using a 
novel lifestyle prescription form (L℞) requiring co-signing by clinician and patient and uniquely 
based on the design of the standard drug prescription form used in primary and secondary 
care settings in the United Kingdom. 
Methods: Thirty-seven participants were recruited with 1 drop out. Thirty-six participants, 18 
doctors (12 secondary care of varying specialties and 6 general practitioners), 15 nurses, and 
3 general practice healthcare assistants, were each issued with an L℞ prescription pad (each 
pad containing 20 sheets) and asked to prescribe each L℞ to suitable patients during 
consultation and log the reason for L℞ issue. Each clinician was then asked to complete a 
feedback questionnaire. 
Results: Forty percent (196 of 480) of the L℞ scripts that were provided to primary and 
secondary care clinicians during the study period were issued (age (mean) 56 years, range 
35-75 years). In most consultations the L℞ was prescribed for dietary advice, 69 and 62% in 
primary and secondary care respectively. Mostly, the L℞ was prescribed as an adjunct to 
prescribing medication (43%) and in response to request for advice from the patient (40%). 
Nurses were more likely to prescribe an L℞ in response to a request for advice from a patient. 
In secondary care, more L℞ were prescribed to males than females (p = 0.017). Doctors 
reported lack of time as a main barrier to using the L℞ and were more likely to report this than 
nurses. 
Discussion: An L℞ is a useful addition in the clinical setting prompting clinicians to give 
lifestyle advice to patients who require lifestyle changes to improve their health. An L℞ is a 
method of distributing lifestyle advice that clinicians would utilise, given sufficient time. The 
main barrier to use experienced in the study was lack of time, this may be due to the L℞ being 
a novel tool. Issuing the L℞ prescription is a method of confirming lifestyle advice that clinicians 
could utilise, particularly with sufficient consultation time.  
Conclusion: The L℞ is a useful addition to the clinician’s communication toolkit to stimulate 
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The dissertation will be organised in chapters as indicated below; 
 
Chapter 1: Introduction  
 
Introduces and briefly defines the topic and background, providing an overview of the 
research.  
 
Chapter 2: Literature Review  
 
Due to the very interdisciplinary nature of this topic and where it sits within the academic filed, 
as well as the novel aspect of a bona fide lifestyle prescription, a very broad scoping literature 
review was conducted which aimed to ascertain how behaviour change in currently instigated 
in practice, by whom and when and if ‘prescribing advice’ would be a useful addition to the 
behaviour change arsenal. This helped to draw conclusions about existing research and the 
possible areas for future research.  
 
Chapter 3: Research Methods  
 
Outlines the overall research methods used to select participants, develop a reliable survey 
and collect and analyse data.  
 
Chapter 4: Results  
 
The results from the surveys are presented. 
 
Chapter 5: Discussion  
 
Discusses the overall outcomes from the research and how the L℞ was perceived and used 
by clinicians. Comparisons are made between primary and secondary care use as well as 
between doctors and nurses/other healthcare professionals followed by a discussion on the 
significance and implications of the study. This chapter summarises key findings and provides 
concluding statements for the dissertation.  
 




Concludes the research overall. 
 
Chapter 7: Future Direction 
 
Discusses the possible future direction for the development and use of the L℞ 
 
Chapter 8: References 
 
Lists the references of the citations in this document 
 
Chapter 9: Appendix 
 









The health of any animal is determined by its genetics, its environment and its behaviour, 
which is also highly determined by the environment. Humans are no different in this regard to 
any other animal (Harari, 2014). However, a key factor which influences human health and is 
especially pertinent in the modern world is the human habitat and its impact on the decisions 
which humans make which in turn effects their health (Kahneman, 2011; Plomin, 1990). 
The science of genetics is inherently complicated and genetic research is expensive as well 
as time consuming. Furthermore, the realities of current science mean that humans still have 
limited control over their own genetics even with the large amounts of money which have been 
invested in genetic, epigenetics and pharmaceutical research (Taylor, Smith, Relton, Gaunt, 
& Richardson, 2018). 
The environment, however, is shaped by human kind (with the exception of the weather). It is 
well established that changing environmental conditions of most sorts has a knock on effect 
on human health in either a positive or negative direction (Haines, Kovats, Campbell-Lendrum, 
& Corvalan, 2006). 
On many metrics the advent of industry and thus the modern world has served human kind 
well, enabling us to grow to a species more than 7 billion strong. However, measured in other 
ways the modern world has caused many problems which can be attributed to a mismatch 
between human genetics and development and the current conditions in which we live 
(Lieberman, 2015). 
The recent changes in the human environment have enabled great strides in longevity by 
reducing the rates of infectious disease but have given rise to ‘diseases of affluence’ 
predominantly due to lack of physical activity, unhealthy diets, cigarette smoking and 
excessive alcohol consumption (Marmot, Adelstein, Robinson, & Rose, 1978). 
These four health harming behaviours are significant in their ability to increase the rate of 
morbidity in a population and are villainous in their mechanism of action due to the slow rate 
of disease progression. Health harming behaviours are highly effective at increasing disability 
adjusted life years, increasing mortality and shortening the life of an individual. Furthermore, 
they are completely avoidable yet insidious in their propensity to overwhelm large amounts of 
a population (Balogh, Papp, Jozan, & Csaszar, 2010). 
The prevalence of health harming behaviours amongst a group of people correlates with the 
other environmental and socioeconomic factors in which the group exists (Prochaska & 
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Velicer, 1997). It is well established that rates of smoking are higher amongst unemployed 
people and people of lower socioeconomic status, likewise for the other three important health 
harming behaviours. Furthermore, harmful behaviours tend to co-exist, such as smoking as 
well as drinking alcohol or not partaking in physical activity and eating an unhealthy diet 
(Akesson, Weismayer, Newby, & Wolk, 2007). It is apparent then that a single health harming 
behaviour can be a confounding factor for the existence of other health harming behaviours.  
These four health harming behaviours are by some estimates responsible for up to 90% of all 
avoidable chronic disease. The very nature of chronic disease means that it is incurable and 
is only manageable with modern medicine (McGill, McMahan, & Gidding, 2008). Nevertheless, 
research has shown that changing health harming behaviours and engaging in health 
promoting behaviours is effective at reducing the chances of having chronic disease as well 
as improving the prognosis for patients with chronic disease (Berenguera et al., 2017). In 
Wales, UK, where this research was conducted, cardiovascular disease is the leading cause 
of mortality with 30% of all deaths attributable to the disease (Dixon & Roberts, 2016). 
It is clear then that the contemporary lifestyle of modern man differs drastically from that of 
our ancestors and this difference is particularly apparent in modern western society which has 
seen the greatest amount of environmental change due to industrial and technological 
development leading to profound changes in human behaviour which in turn influences 
disease risk factors attributable to lifestyle (Harari, 2014). 
Given this knowledge of the detrimental nature of health harming behaviours, it has become 
apparent in recent years that it is necessary for public health to promote healthy behaviour as 
well as restrict the use of health harming substances such as cigarettes and alcohol by legal 
means and taxation (Shroufi et al., 2013). Changing physical activity and dietary behaviour is 
more difficult. Attaining a good level of physical activity is seen by many as challenging due to 
the nature of modern work and its mostly sedentary basis. Changing diet is also viewed as 
challenging and may depend on the environmental context of each individual and their 
knowledge and prior customs of eating. Nevertheless, the modern food industry has played a 
huge role in changing people’s diets since the end of World War 2 and this has had mostly 
detrimental effects in terms of diversity of nutritional quality (Nesheim et al., 2015). There have 
been numerous interventions and incentives designed and implemented by policy makers and 
Public Health groups to improve the health of the nation. Some of these policies have greater 
effect than others (Kelly & Barker, 2016). 
Social prescribing has gained a greater interest in recent years as a means of improving health 
in communities, particularly in the mental health arena. Furthermore, patients have a long-
standing respect for prescription forms issued by a prescribing clinician and are also used to 
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using them. Due to these facts of prescribing, the concept of prescribing lifestyle advice for 
multiple health harming behaviours and also signposting patients to relevant help services 
was born (Brandling & House, 2009). 
This dissertation outlines the evidence that exists for prescriptive lifestyle changes and their 
usefulness in changing behaviour to initiate healthier lifestyles and thus improve health 
outcomes. Importantly, this dissertation explores the clinician side of the behaviour change 
method by assessing how clinicians feel about giving advice to instigate behaviour change 
and how they feel about giving advice in a prescriptive manner in particular. This dissertation 
examines the usefulness of what is, in essence, prescribing advice to patients with a material 
tool in the hope that it instigates change. 
The main objective of the research outlined in this dissertation was to investigate clinicians’ 
perceptions of a novel ‘lifestyle prescription’ commissioned and developed by Public Health 
Wales with advice from numerous stakeholders in the health arena. The Lifestyle Prescription 
form (L℞) was a script designed in the image of a standard prescription form and was designed 
to be used by any medical practitioner. The L℞ was created with the aim of instigating a 
behaviour change conversation by the medical practitioner with the patient and to provide the 
patient with consistent, concise and appropriate information regarding the most common 
health harming behaviours. The L℞ was designed to be a useful script in the fight to address 
health inequalities that exist in Wales, which strongly correlate with health harming 





2.0 Literature Review 
2.1 Purpose and Scope 
 
This literature review is being conducted as the initial component for a research project with 
the title ‘Prescribing behaviour change for cardiovascular health’. 
The review has the objective of assessing the methods by which a behaviour change 
conversation or ‘intervention’ is instigated into a patient plan of healthcare in the primary care 
and secondary care arena whilst determining from the literature where and how a lifestyle 
prescription will fit. 
The predominant targets of assessment being how the behaviour change conversation, 
leading to a process, is attempted in the healthcare setting, by which type of practitioner it is 
most frequently delivered, and what is being conveyed in the conversation. 
The review aims to determine if there is evidence for the use of behaviour change materials 
in the initiation of a behaviour change conversation between a healthcare practitioner and the 
patient. 
The literature review considered research from the public health and clinical medicine 
disciplines as well as a significant amount of literature from the field of psychology, most 




2.2 Search Strategy 
 
To conduct this literature review the following databases were searched: CINAHL plus, 
MedLine, PubMed, PsychINFO using a search strategy planner developed by Public Health 
Wales (figure 1). Reference lists of relevant articles were also searched. Key terms including 
‘behaviour change’, ‘cardiovascular health’, ‘primary care’, ‘behavioural interventions’, 
‘patients’ and related synonyms of each term were used in the advanced search function of 
the databases using query strings and MeSH headings were used in Pubmed. 
 
A search strategy planner was used to help guide the literature search for this report (Figure 
1).  








2.3 Cardiovascular disease 
 
Cardiovascular disease (CVD) is a catch-all term for a multitude of linked pathologies including 
coronary heart disease, cerebrovascular disease, peripheral arterial disease, rheumatic and 
congenital heart diseases and venous thromboembolism (Masana et al., 2017). CVD remains 
the leading cause of death in the United Kingdom and globally despite decades of research 
and development to target the disease. In 2014, 28% of male and 26% of female mortality of 
all ages was attributable to cardiovascular disease, according to the British Heart Foundation 
statistics compendium 2015 (Townsend, Wickramasinghe, Williams, Bhatnagar, & Rayner, 
2015). In Wales, CVD accounts for around a third of all mortality and costs the National Health 
Service (NHS) and the UK economy £30 billion annually (The Welsh Government, 2017a). In 
2010/2011, there were 1.4million CVD-related hospital admissions, of which 60% were for 
people younger than 75 and more than half as an emergency (Hill et al., 2013). 
It is well documented that behavioural choices are associated with an increased 
preponderance to developing CVD - major contributing behaviours being; cigarette smoking, 
not performing enough physical activity, eating an unhealthy diet lacking nutritional quality but 
with excessive calories and consuming excessive amounts of alcohol. These are 4 of the 
greatest behavioural contributors to CVD in the western world, especially in the UK and 
importantly in Wales with up to 90% of all CV mortality linked to these health harming 
behaviours (Khaw et al., 2008; Yusuf et al., 2004). 
Knowledge of risk is essential for the adoption of healthy lifestyle behaviours related to diet, 
exercise, smoking and alcohol consumption. Critically, up to 40% of the general population 
underestimate their CVD risk. False reassurance may lead to adoption and/or maintenance of 
unhealthy behaviours contributing to the premature onset of CVD. Lower CVD risk awareness 
is reported among men, inner city residents and people of lower socioeconomic status (Hill et 
al. 2013). 
The INTERHEART study provided a good illumination of the main CVD risk factors. Notably, 
it was shown that healthy behaviours were effective at preventing CVD across the 
socioeconomic strata. It was found that health harming behaviours tend to co-exist to the same 
extent that health promoting behaviours do. It is also known that although age is said to be a 
risk factor for the development of CVD, evidence suggests that age isn’t a determinant of CVD, 
growing older does not guarantee developing CVD. Therefore, behavioural changes that 
reduce health harming behaviours are crucial for preventing CVD regardless of socioeconomic 
background or other social and environmental fact (Yusuf et al., 2004). 
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There is a wealth of scientific evidence that demonstrates the relevance of a healthy lifestyle 
(the lack of health harming behaviours) for the aetiology of CVD (Chomistek et al., 2015; Iso, 
2011; Masana et al., 2017; Rautio et al., 2015). Crucially, progression of cardiovascular 
disease may be ablated by changes in lifestyle. 
2.4 The healthcare setting 
 
Primary care (PC) is ordinarily the first point of contact for health matters for the public. Primary 
care is provided by general practitioners (GPs) and also by nurse practitioners (NPs), as well 
as community pharmacists, opticians and dentists. Each of these practitioners is equally 
responsible for ‘making every consultation count’ (MECC) (Percival, 2014) and therefore 
responsible for asking patients about their lifestyle and health harming behaviours. 
The predominant aim of primary care is to provide people with an easily accessible health 
service that enables continuity of care and follow up appointments. Primary care exists to care 
for people, rather than targeting interventions for specific diseases which are normally dealt 
with by a specialist consultant. This means that primary care healthcare professionals are 
generalists and ‘holistic’ in their approach to physical, psychological or social problems 
(Jallinoja et al., 2007). 
Primary care practitioners are in the important and unique position to promote harm reducing 
behaviours and behavioural changes to patients at risk of CVD or with existing symptoms of 
CVD, in the local community. On average, people visit their general practitioner or local health 
clinic 5.4 times per person per annum, with over 80% of the UK population consulting with 
general practice annually (Butler et al., 2013). This puts primary care truly at the tip of the 
spear for initiating lifestyle change interventions to the population. Primary care practitioners 
are therefore crucial to the task of reducing health harming behaviours in the population by 
MECC and intervening when appropriate with referrals and importantly brief interventions in 
consultations (Haller, Pfarrwaller, Cerutti, & Gaspoz, 2016). 
Clearly, all of the available evidence points to the promotion of risk reduction strategies and 
instigating conversation around behaviour change at every available opportunity in the 
healthcare setting. Promoting good CV health has myriad benefits for society and the 
economy, not least lower prevalence of morbidity and increased wellbeing but also reduced 
costs to the health service. 
The challenge, however, is extraordinarily large due to the complexity of human behaviour 






Human behaviour is determined by genetic, social, environmental and cultural factors, 
amongst other influences. Behaviours determine the actions people make and the responses 
they have to all stimuli. Behaviours are controlled by both the nervous system and the 
endocrine system; it is known that the more complex an animal’s nervous system, the more 
complex their behaviours tend to be due to the ability to learn and adapt to stimuli from the 
environment over time (Davis, Campbell, Hildon, Hobbs, & Michie, 2015). 
Behaviour is impacted by each individual’s personality traits and temperament but is heavily 
influenced by the environment and context of any given situation which a person finds 
themselves in. Behaviours can change over a lifetime as context changes, health changes, 
mental acuity changes and many other factors both internally and externally. Therefore, it is 
clear that this area of psychology is broad, incredibly complex and completely intertwined with 
many other academic fields including anthropology, evolutionary biology, sociology, 
philosophy, theology and numerous others (Bandura, 1999). Societal norms also largely 
influence behaviour, these are cultural influences. Culture is the driving force of modern 
human development. In recent millennia culture has taken over from biological influences to 
drive human evolution and progress. The ideological or ‘political’ zeitgeist has been an 
especially strong force for change well illustrated in the stark contrasts of the 1960s Soviet 
Union and United States. These environments directly determine the behaviour of the human 
and therefore its health. 
For the purpose of this literature review, human behaviour can be thought of as; ‘the product 
of individual or collective human actions, seen within and influenced by their structural, social 
and economic context’ (National Institute for Health and Care Excellence, 2007) or as 
‘anything a person does in response to internal or external events’. This definition is agreed 
across multiple disciplines including psychology, sociology, anthropology and economics. 
Actions may be tangible and intangible and overt or covert (Chauhan et al., 2017). 
It is because of the complexity of human behaviour due to internal and external stimuli that 
developing behaviour change policy, techniques or interventions and shaping the choices 




2.6 Behaviour change 
 
Behaviour change is a distinct area of behavioural psychology and involves the use of theories 
to develop interventions to change human behaviour. Behaviour change is utilised in different 
fields of research and policy including health, environment, education and government 
amongst others, all with the same goals of promoting better behaviour than the current 
behaviours which may be detrimental to health or harmful to the environment or other people 
in myriad ways (Masana et al., 2017). 
It is necessary to have an understanding and a definition as to what constitutes behaviour 
change to develop appropriate and effective interventions. This entails being aware of the 
theoretical underpinnings of behaviour change. In the context of behavioural psychology, 
theories are the accumulated knowledge of the mechanisms of action and moderators of 
change and also the underlying understanding and assumptions of what human behaviour is 
and entails (Michie, van Stralen, & West, 2011). Research indicates that behaviour can be 
effectively modified through interventions that target behaviours with specificity and precision, 
especially in the short term. However, long term sustainability of behavioural change from 
multiple interventions is less well established (Artinian et al., 2010). There is less evidence for 
long term effectiveness of behaviour change interventions and long-term interventions have 
been less evaluated with fewer studies looking into the effects of interventions over the course 
of several years as opposed to a number of months. It seems apparent that the effects of 
behavioural interventions, even those backed by a theory of behavioural change, can diminish 
over time as people revert back to old habits or old methods of action indicative of the hard-
wired nature of certain behaviours, especially those that are health related (Kwasnicka, 
Dombrowski, White, & Sniehotta, 2016; Ryan & Deci, 2000). 
When dealing with health-related behaviour change it is even more imperative to be aware of 
the nature of certain behavioural ‘choices’ and the insidious nature of addiction (Katikireddi, 
Green, Taylor, Smith, & Munafò, 2017). Not only this but due to the nature of our society and 
its foundations of consumerism and strong marketing strategies, it is far easier to revert back 
to drinking alcohol, smoking and eating an unhealthy diet or not exercising than it is to stick to 
a new behaviour which has not yet reached the stage of ‘maintenance’ in the stages of change 
model (Norcross, Krebs, & Prochaska, 2011). Reaching the maintenance stage can require 
many years of continued dedication to a new behaviour, all the while the person trying to 
change is most likely living in the same environment since they tried to change, is spending 
time doing the same things and is influenced by the same people in the same context (Miller 
& Rollnick, 2004). Therefore, there is much stacked up against an individual trying to change 
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their behaviour, no matter the theory behind the intervention! 
It is important to understand the mechanisms of action that enable some behaviour change 
strategies to ‘stick’ and therefore be effective in the long term to design interventions and 
strategies which are cost effective and beneficial rather than wasting time, money and 
resources designing and implementing interventions which only have a short-term effect. Not 
to mention the ethical considerations of giving patients behaviour change interventions which 
do not provide long term health advantage but also potentially cause a disadvantage in the 
short term as the patient must undergo the stages of change which can be disruptive and 
stressful. 
2.7 Behaviour change theory 
 
In the psychological literature, theory is defined as a set of statements that organises, predicts 
and explains observations. Theory explains how phenomena relate to each other, and what 
can be expected under unknown conditions (Michie & van Stralen et al. 2011). Theory may 
be useful for research to improve our understanding of maintained behaviour as well as for 
the design and implementation of interventions to achieve behaviour change maintenance 
(Johnson & May, 2015). A theory is a set of interrelated concepts, definitions, and propositions 
that explains or predicts events or situations by specifying relations among variables. Health 
behaviour theories reflect an amalgamation of approaches, methods, and strategies from 
social and health sciences (Davis et al., 2015). 
Health behaviour change theories, including the Integrated Theory of Health Behaviour 
Change,  are general which enables them to have a broad application and are therefore useful 
in numerous different interventions by not being overly specific for any one single intervention. 
For example, the stages of change theory may be applied to interventions which target 
smoking cessation or physical activity promotion. Each theory utilises specific vocabulary to 
delineate differences between terms and concepts and thus articulate the specificities of that 
theory (Johnson & May, 2015). 
Behaviour change theories may be explanatory, change theory or both. Explanatory theory 
enables understanding of why behaviours are performed and change theory enables 
interventions to be developed to change the behaviour. Often behaviour change theories are 
both. Theory enables understanding of why people do or do not practice health promoting 
behaviours or health harming behaviours. Theories also enable the identification of what is 
needed to develop successful intervention strategies targeting specific groups or populations. 
Explanatory and change theory require an understanding of the social determinants of health 
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and behaviour. This is because behaviour is determined by environmental, economic, social, 
cultural and individual factors. Therefore, interventions are more likely to be effective when 
the multitude of contributing factors to a behaviour are taken into account. Interventions should 
not only be targeted at individuals but should also affect interpersonal, organisational, and 
environmental factors influencing health behaviour (Michie, Johnston, Francis, Hardeman, & 
Eccles, 2008). 
There is consensus in the behaviour change community of researchers and practitioners that 
basing interventions on behaviour change theory is more scientifically rigorous and provides 
greater effectiveness of intervention design and outcome (Michie et al., 2013). Nevertheless, 
there is conflicting literature regarding whether or not utilising theory when developing 
behaviour change interventions is more effective or not. One review has found positive effects 
(Albada, Ausems, Bensing, & van Dulmen, 2009) for the use of theory in developing 
interventions whereas another has not (Gardner, Wardle, Poston, & Croker, 2011). 
Nevertheless, theory can be developed and is able to be evaluated and makes interventions 
easier to evaluate in a more logical manner. Theory based interventions enable the 
development of the intervention by facilitating an understanding of what works and does not 
work which enables specific development of theory across different contexts, populations and 
behaviours. It also enables interventions to be more malleable to different socio-economic 
contexts (Bandura, 1999). 
Behaviour change techniques (BCT) are the active ingredients to any intervention delivered 
to a patient in a healthcare setting. A behaviour change technique can be defined as an 
“observable, replicable and irreducible component of an intervention designed to alter or 
redirect causal processes that regulate behaviour” (Michie et al. 2013). In this fashion, the 
BCT is the part of the intervention which is key to initiating the behavioural change and can 
be monitored. 
To allow the accurate assessment of any given BCT used in a healthcare setting it is 
necessary to understand what the active components of the BCT are. Without a classification 
system, it is impossible to accurately replicate a BCT and therefore difficult to inform its 
development (Michie et al. 2008). Underspecified BCTs are not able to be replicated and 
delivered with fidelity. In addition, many interventions are conducted without any underlying 
scientific theory thus it is difficult to accurately pin point the type of BCT which is being used 
in an intervention and with what justification and to what end. 
Delivering behaviour change in health care must involve the use of communication between 
the practitioner and the patient. Effective communication is necessary to enable the patient to 
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understand their behaviours effects on their own health and for the patient to deem change as 
beneficial. BCTs are used by practitioners to communicate effectively to patients to initiate 
specific behavioural changes. 
2.8 Health behaviour change leads to positive health outcomes 
 
It is well established that changing key health behaviours including smoking cessation, 
reducing alcohol consumption, eating a diet high in vegetables and fruit and reducing 
sedentary time leads to vastly improved health outcomes including fewer disability adjusted 
life years and reduced all-cause mortality (Cassidy, 2015; Chomistek et al., 2015; Masana et 
al., 2017; Rautio et al., 2015; P. Ryan, 2009).  
 
These measures are best instigated to prevent the onset of chronic disease from taking place 
but are also effective at improving health outcomes for those that have chronic disease 
symptoms too (Brodie & Inoue, 2005). 
 
This fact is the fundamental basis for the need and public health drive to create effective health 
promotion initiatives, interventions and resources that engage people to make proactive and 
positive steps for their health by attenuating health harming behaviours. To ‘change’ people – 
for the betterment of their health. 
 
The EPIC Norfolk study found a strong link between an increase of positive health behaviours 
and reduced all-cause mortality. The prospective study examined 20,244 men and women 
aged 45-79 years who had no known CVD or cancer at baseline and followed up this group 
11 years later in 2006. This study indicated that the effect of engaging in positive health 
behaviours is additive. The more positive health behaviours participants in the study engaged 
in, the better their health and reduced mortality (Khaw et al., 2008). 
 
A systematic review found that health behaviours also have a clustering effect. Engaging in 
one healthy behaviour means a person is more likely to engage in another healthy behaviour 
and vice versa for health harming behaviours (Meader et al., 2016) This systematic review 
provided evidence for the use of multiple health harming behaviour change interventions to 
improve all round health, by targeting health behaviours sequentially or concurrently where 
there is evidence of health harming behaviour clustering – often present in people who smoke 






2.9 Self Efficacy Theory 
 
Self-efficacy is an individual’s capacity to follow through with their goals and plans as related 
to their personal believes and feelings of self-worth (Bandura, 1999).  
 
Health behaviour choices have a strong link to an individual’s self-efficacy. Those high in self-
efficacy make better health choices than those low in self-efficacy (Dr, Scholz, & Schwarzer, 
2005).  
 
Self-efficacy theory is a useful theory to consider in the design, implementation and use of the 
LRx due to the use of the LRx being a self-directed by the patient in an autonomous manner. 
Although the LRx is prescribed by a clinician, the ownership of the instructions falls solely on 
the patient and thus how well followed the instructions of the LRx are depends highly on the 
patient’s self-efficacy.  
 
Taking this theory into account, the LRx was designed with prompts for the patient to contact 
services that are able to help with their behaviour change. Nevertheless, if the patient is very 
low in self-efficacy it may difficult for them to follow instructions given by a clinician, even if 





For behaviour change to take place it is necessary that the individual has prerequisites in 
place to enable the change, which include the skills necessary to perform the change, the 
intention to change and the environmental capacity without undue hindrance. The COM-B 
model of behaviour change (Figure 2) is a framework and theory that stands for capability, 










2. The COM – B Model illustrating the interactions and influences of opportunity, 
personal motivation and personal capability on a person’s behaviour. 
 
 
to interact with each other and explain why behaviour sticks or changes in each circumstance 
or context (Fishbein, Triandis, Kanfer, Becker, & Middlestadt, 2000). 
Change requires volition, known colloquially as ‘willpower’, which is a fundamental human 
cognitive process by which an individual decides upon pursuing a specific course of action or 
objective and carries out the necessary undertaking; purposeful striving. Michie et al (2011) 
also proposed that behaviour change could be looked at in the same view that the US criminal 
justice system assess a person as being guilty of a crime. These factors include a person 
having means or capability, opportunity and motive. These factors are not only necessary to 
commit a crime, but also necessary for one to engage in any volitional behaviour, including 
change. 
Capability, in both psychological and physical terms, is the capacity an individual has to 
engage in any given activity by having the necessary knowledge and skillset that are required. 
Motivation is a fundamentally psychological phenomenon that directs behaviour. Opportunity 
is the encompassment of all the factors which may lie outside of individual control which may 
prompt behaviour or action. Opportunity can influence motivation as can capability; enacting 
a behaviour can alter capability, motivation, and opportunity (Michie & Ashford et al. 2011; 
Davis et al. 2015). 
COM- B as a model for behaviour can be applied to patients to identify the components of a 
behaviour and how they can be changed using an appropriate intervention, but it can also be 
applied to clinician’s behaviour and used to determine the influences and factors which prompt 
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clinician’s to engage patients in a behaviour change conversation (Jackson et al. 2014). 
2.11 Motivational interviewing 
 
Motivational interviewing (MI) is a type of counselling advice developed to interact with hard 
to change addicts. It is a directive method which aims to remove the ambivalence which 
patients may feel about making behavioural changes. MI is patient centred and aims to 
enhance the patient’s intrinsic motivations to change. The method was first described by Miller 
in 1983 as an approach to treat alcoholics (Rubak et al. 2005; Miller & Rollnick 2004). 
MI is now a widely used counselling method to help clients with CVDs to modify their unhealthy 
lifestyle and thus decrease their risk of disease occurrence. Practicing MI requires the ability 
to ask open-ended questions, the ability to provide affirmations, the capacity for reflective 
listening, and the ability to periodically provide summary statements to the client. Therefore, it 
is important a clinician has the necessary skillset to perform MI (Brobeck et al. 2014). 
Nevertheless, MI has been demonstrated to be easy to learn and implement in short 
consultations of less than 15 minutes duration (Brodie & Inoue 2005). Motivational interviewing 
may be used in brief interventions to encourage patients to change unhealthy behaviour which 
can benefit their cardiovascular health (Emmen et al. 2004). 
The delivery of behavioural change advice from the practicing clinician is imperative for the 
patient to initiate change of their health harming behaviour. Importantly, if clinicians do not give 
advice on lifestyle changes the patient may consider their behaviour to be irrelevant for their 
predisposition for developing disease or even not responsible for their current disease state. 
MI is a good method of delivery of advice to the patient as the aim is to avoid putting the patient 
on the defensive (Brodie & Inoue 2005). 
Interestingly, a systematic literature review by Lee et al. (2016) of the MI technique which 
considered 9 randomised control trials (in which the trials evaluated lifestyle modifications 
included smoking habit, physical activity, and alteration in dietary habits, such as increase in 
fruit and vegetable intake and decrease in fat intake) found that among all of these lifestyle 
outcomes, MI exhibited significant positive effect on smoking habit only (Lee et al. 2016). 
Moreover, the deliverers of the intervention and the associated training they received also 
varied among the studies. Deliverers included nurses, physicians, physical activity specialists, 
life coach, dietitians, and so on. This heterogeneity in the background of the intervention 
deliverers complicated the determination whether professionals may have exerted a different 
degree of effort on a particular outcome based on their own expertise. In addition, six studies 
mentioned that MI training was provided to the staff who delivered the intervention, whereas 
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the three remaining studies did not mention it. 
Currently, motivational interviewing is utilised in a primary care setting and on an impromptu 
basis (Hardcastle et al. 2013). Motivational interviewing may be successfully utilised alongside 
a prescription such as the L� to better enhance the guidance being given by the clinician to 
the patient. It may be possible to form the behaviour change conversation around the L� as 
well as prompting the clinician to ask appropriate questions. 
2.12 Transtheoretical model 
 
The stages of change model developed by Prochaska & Velicer (1997) provides a solid 
framework enabling a primary healthcare practitioner to implement behavioural interventions 
utilising the motivational interviewing technique. 
According to the TTM, the stages of change are; precontemplation, contemplation, 
preparation, action, and maintenance of the behavioural change. 
Precontemplation means the individual is either unaware or is completely not willing to make 
any change. Contemplation means the individual is aware there is a problem and is 
considering making a change. Preparation is the stage in which an individual is ready to make 
a change in the near future. Action is the stage in which the individual is implementing a 
behavioural change and maintenance is when the individual is trying to sustain the change 
that has been made. It is not uncommon for individuals to move backwards and forwards along 
the path of the stages of change until eventually coming to the maintenance stage and staying 
there permanently. Therefore, the TTM model allows the process of change to be a cyclical 
event with the individual progressing but also regressing, often multiple times, throughout the 
change process. 
Of note, 68% of patients seen in primary care are in the precontemplative stage and 
contemplative stage of change (Norcross et al. 2011). This statistic is imperative to be aware 
of when implementing interventional strategies in primary care and when making policy which 
consider making every consultation count. Due to the nature of the precontemplative stage it 
is important that the clinician is aware that the patient may become defensive if directly 
challenged about their behaviour and thus a motivational interviewing method would be more 
effective at engaging them. 
Nevertheless, this statistic also indicates the important position that healthcare providers, 
especially primary care practitioners, are in to initiate patient behaviour change of health 




It is therefore crucial that practitioners are taking every available opportunity to initiate a 
behaviour change conversation with the vast majority of patients which they come into contact 
with to promote a healthy lifestyle and take advantage of the ‘teachable moment’ and the 
power that the clinician has in giving advice to patients that counts (McBride, Emmons, & 
Lipkus, 2003). This scenario is a part of ‘making every consultation count’ which is now part 
of UK government health policy (Lawrence et al., 2016). 
This evidence is crucial to consider for the use of a lifestyle prescription form. The script is 
able to act as a prompt for the practising clinician to give advice as well as provide guidance 
for the patient when they leave the consultation room. This, what is in essence a brief 
intervention, could act as the catalyst for progressing the patient into the next ‘stage of change’ 
which would be preparation. 
2.13 Health belief model 
 
According to the health belief model (HBM), individuals who have accurate knowledge of CVD 
and perceived susceptibility to and consequences of the disease, and are aware of the 
benefits of taking preventive measures are more likely to make important lifestyle choices to 
prevent the onset of disease (Green & Murphy, 2014). Most theories applied to public health 
interventions tend to emphasise individual capabilities and motivation, with limited reference 
to context and social factors. Intervention effectiveness may be increased by drawing on a 
wider range of theories incorporating social, cultural and economic factors that influence 
behaviour. 
The health belief model is drawn upon in the development and use of the L� as it is a tool 
which informs patients of risks to their health from health harming behaviours. 
2.14 Multiple health behaviour change 
 
As health harming behaviours regularly co-exist it makes sense to target the detrimental 
behaviours synergistically. Multiple health behaviour change (MHBC) interventions aim to 
address a spectrum of health harming behaviours. MHBC are often necessary due to the 
frequent co-existence of disadvantageous behaviour such as smoking and drinking or 
smoking and lack of physical activity. In the same way that unhealthy behaviours tend to co-
exist healthy behaviours do so too. People who choose to eat healthily are more likely to 
partake in more physical activity (Goldstein, Whitlock, & DePue, 2004). 
29 
 
However, a recent systematic review and meta-analysis by Alageel et al. (2017) of 31 trials 
with a total of 36,484 participants found that targeting multiple health behaviour change 
interventions to patients in primary care with the risk factors for cardiovascular disease did not 
have any statistically positive effects on any physiological metrics which are CVD risk factors 
(Alageel, Gulliford, McDermott, & Wright, 2017). 
Nevertheless, it was concluded by Alageel et al. (2017) that published experimental reports 
are not adequately providing information on the behavioural change theory which is being 
used when delivering health harming behaviour interventions targeting cardiovascular 
disease. The systematic review concluded that it is necessary that BCTs are properly recorded 
and coded in studies which utilise them to enable further development of interventions and 
behaviour techniques in primary care and thus to be able to provide proper evidence based 
behaviour change counselling and intervention (Alageel et al., 2017). 
This point is reinforced by evidence from Michie et al. (2013) whom concluded the need for a 
strict behaviour change intervention taxonomy to accurately develop and initiate behaviour 
change interventions, especially when the interventions target multiple behaviours. It is 
possible that interventions can become too broad and with a lack of theoretical backing which 




2.15 Clinician engagement 
 
Clinicians often report feeling ill-prepared or ill-trained to engage patients in conversation 
about their health harming behaviours and health harming lifestyle choices. Clinicians are well 
trained to deal with the outcomes of these health harming behaviours such as cardiovascular 
disease by prescribing pharmacological interventions or referring to specialists for treatment 
but are often lacking in the skills, competence or capability to initiate behaviour change in their 
patients which would lead to better health outcomes and crucially save the health service time, 
money and resources (Jackson et al. 2014). One clinician described this as “firefighting” as 
opposed to preventing the chronic disease outcome from ill lifestyle. 
The COM-B model can be applied to the clinician’s ability to perform behaviour change as well 
as the patient’s ability to undertake behaviour change. In fact, research has demonstrated that 
medical practitioners may need to undergo their own behaviour change to actually perform 
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behavioural change interventions with patients. This is due to practitioners becoming 
comfortable with a standard way of operating and not diverging into unknown territory in terms 
of treating their patients (Cook, Montori, McMullin, Finfer, & Rocker, 2004). 
Using the COM-B model it can be seen that clinicians have the capability to perform behaviour 
change interventions with their patients if they are trained and if they have the tools to perform 
such an intervention. Clinicians have the opportunity to engage patients in behavioural change 
every time they have a consultation with a patient - a ‘teachable moment’. Motivation to 
perform behavioural change with patients then depends on the contextual circumstances for 
each different practitioner and also whether they practice in a primary or secondary care 
environment. Typically, it could be expected that motivation to engage patients in behaviour 
change should be high as the more patients engage in behavioural change and thus reduce 
their health harming behaviours, the less burden would be placed on the health service - both 
primary and secondary. 
Using an L� may provide clinicians with the confidence to attempt a behaviour change 
conversation even if the clinician has not received any formal training (Kaner & McGovern 
2013). An L� also highlights to the clinician the opportunity which has been presented to them 
by way of instigating a behaviour change conversation as the L� is a material, desk-based 
resource which acts a prompt. 
In a study of GP perceptions of using a New Zealand green prescription form (GRx), it was 
found that the main barrier the clinician faced, in giving advice on and referring with a green 
prescription, was time. GPs were confident and competent at using green prescriptions to 
refer patients to support services that enabled them to engage more in physical activity and 
receive nutrition counselling (Patel et al. 2011). 
Patients may respond differently to clinicians giving behaviour change advice. Nurses have 
more training in delivering interventions to patients and giving lifestyle advice but physicians 
may have more authority to give advice in the eyes of the patient (Noordman et al. 2012). 
Therefore, taking this into account it was expected that the L� would be utilised differently by 
different types of clinicians as well as prescribed to different groups of patients depending on 
the kind of clinician prescribing it. 
2.16 Who gives lifestyle advice? 
 
From the literature search it appeared that lifestyle advice is given by many different clinicians 
and in varied settings including in primary and secondary care. 
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Doctors may be seen as having more authority for giving lifestyle advice to patients due to 
their status as being at the top of the medical hierarchy. In this sense, lifestyle advice may be 
more effectively administered when given by doctors (Keyworth et al. 2016). 
Nurses and other allied health professionals seem to spend more time talking to patients about 
lifestyle changes than doctors do in consultations. It is apparent that the predominant reason 
for this is doctor cited lack of time Lundberg et al. (2016). 
Nurses may be better suited to giving lifestyle advice due to their more regular engagement 
of such socioeconomic health related issues whereas doctors may be more comfortable 
dealing with health issues which require pharmacological treatment (Brobeck et al. 2014). 
Doctors are naturally trained in prescribing pharmaceuticals for ailments than they are 
behavioural changes or other kinds of social prescriptions. Due to this, nurses may be more 
appropriately trained in delivering behaviour change advice in varied clinical settings because 
of their potential malleability in delivering a prescription which they have not routinely done 
before. 
A study by Lawlor (2000) determined that general practitioners do not see it as their role to 
engage in a population wide lifestyle change approach. GP’s felt that their role was more of 
secondary prevention rather than being the tip of the spear in terms of preventing health 
harming behaviours in the population. From the study, it was determined that general 
practitioners were of the opinion that the preferred way to improve population wide health 
harming behaviours was to instigate it with a centrally co-ordinated approach and via multiple 
agencies (Lawlor et al. 2000). 
2.17 Evidence of prescriptive advice 
 
It is not clear from the literature whether written advice issued by a medical practitioner is more 
effective at changing patient behaviour than verbal advice alone. Brief interventions conducted 
by a doctor or nurse are normally performed with verbal instruction/ advice giving and using a 
method similar to or the same as the motivational interviewing form which has good evidence 
and training associated with it. 
Nevertheless, in a green prescription study it was found that written and goal-oriented advice 
in the form of a prescription was effective at increasing exercise participation amongst a wide 
patient group (Swinburn et al. 1998). This finding is in line with research by Michie et al. (2008) 
who determined the most successful methods of changing lifestyle behaviour, self-efficacy 




The green prescription has a vast amount of literature dedicated to its use and feasibility, 
predominantly in the primary care setting in New Zealand. The research of the green 
prescription is useful in the development of a lifestyle prescription for Wales, UK due to the 
very similar demographics and geographical circumstances of the two populations. 
The New Zealand Green Prescription is a public health intervention developed in the 1990’s 
to improve New Zealander’s activity levels and has been successfully used especially in 
improving exercise adherence amongst lower socioeconomic classes. The key element to the 
Green Prescription is its administration as a bona fide prescription (Swinburn et al. 1998). 
A systematic review by Orrow et al. (2012) of 15 trials with 8745 participants determine that 
promotion of physical activity to sedentary adults is useful in improving physical activity levels 
over a period of 12 months but they could not find sufficient evidence that physical activity 
promotion schemes are more effective at changing behaviour than other advice or counselling 
schemes. It was determined that longer periods of follow up were necessary to evaluate the 
effectiveness of changing physical activity behaviour in the long term which would thus 
indicate that behaviour change had successfully taken place (Orrow et al. 2012). 
This is relevant as the L� is a script designed to be used by any prescribing clinician regardless 
of their training in behaviour change or counselling. Furthermore, the L� does not refer the 
patient but instead signposts the patient to services which would be able to provide help, 
support and counselling including services such as ‘Help me Quit’ in Wales, a service run by 
Public Health Wales (helpmequit.wales 2018). 
Therefore, although written instructions in the form of a prescription are known to be valued 
and respected by patients it is not clear whether or not written advice would be more effective 
than verbal advice in changing patients’ health harming behaviour (Johnson & May 2015). 
However, written communication is beneficial in the continuity and in the standardisation that 
it enables when providing patients with health information and guidance. It may be beneficial 
for the prescribing clinician to give personalised verbal guidance alongside written formalised 
and standardised instruction. 
Nevertheless, the aim of the L� is not to replace a verbal advice or a behaviour change 
conversation but to in fact instigate the conversation in the first place. The L� has a main aim 
of being a prompt and an instigator of clinician interaction with the patient to discuss lifestyle 
behaviour and to provide a template for conversation. 
Prescription forms are used by healthcare practitioners and it is known that practitioners are 
comfortable using these forms. This comfortability with a familiar tool may encourage clinicians 
to use the L� in any given consultation- when appropriate. Crucially, it will be appropriate most 
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of the time, due to the large percentage of the population who present to general practice or 
a hospital with health harming behaviours. Furthermore, general practice in New Zealand and 
the United Kingdom is an ideal setting to identify sedentary adults and deliver brief 
interventions advising on physical activity as more than 80% of adults visit at least once a year 
(Elley et al. 2003). After decades of limited success in incorporating health behaviour issues 
into medical practice, a key challenge was how to engage those primary care clinicians who 
are in small- to medium-sized primary care practices, the dominant model of primary care 
delivery in the healthcare system.  
The “green prescription” (GRx) intervention may be a suitable model to base the future 
development of the L� on. In the GRx method primary care clinicians are engaged in four 
hours of training of the motivational interviewing methodology to give them the competency to 
effectively administer the GRx to patients. Patients are identified early on through a screening 
system conducted by receptionists in primary care and issued with a prompt card which states 
the patients ‘stage of change’ (physical activity) which the patient then hands to the consulting 
clinician. The clinician then discusses this lifestyle behaviours with the patient and determines 
suitable goals for the patient to work towards. The goals are written on a standard green 
prescription which is prescribed to the patient and a copy is faxed to the local sports foundation 
who make contact with the patient to provide support and encouragement, also utilising the 
motivational interviewing method (Elley et al. 2003). 
Elley et al. (2003) found that the GRx was an effective intervention conducted via general 
practice for increasing participant’s physical activity levels and improving their quality of life 
over 12 months without any evidence of adverse effects. Furthermore, it was also found that 
there was a trend in participant’s blood pressure decreasing. However, no significant decrease 
in coronary heart disease risk was demonstrated. Of note, it was found that for every 10 green 
prescriptions written, one person achieved and sustained 150 minutes of moderate or vigorous 
leisure activity per week, at 12 months. Achieving this amount of activity (using up an additional 
1000 kcal/week) is associated with a 20-30% risk reduction in all-cause mortality compared 
with sedentary individuals (Elley et al. 2003). 
More research into the GRx by Hamlin et al. (2016) on the long term effectiveness of the GRx 
indicated that the GRx is even effective over periods of 2-3 years for both males and females. 
They concluded that to improve the rates of compliance with the GRx, better communication 
was necessary between service providers. However, such a long period of effectiveness for a 
behaviour change intervention is of note due to the preponderance of behaviour change 




Swinburn et al. (1998) attests to the use of prescription forms for guiding behaviour change 
issues. General practitioners have access to a large proportion of the population who engage 
in health harming behaviours. Therefore, the prescription is an appealing paradigm to issue 
behaviour change as they represent a well understood interaction between clinician and 
patient. The prescription enables tangible goals to be set with information and advice as well 
as reducing the burden placed on primary care and easing the amount of time taken to provide 
lifestyle advice (Swinburn et al. 1998). 
Additionally, the GRx was more effective over a 6 week period than verbal advice alone in 
increasing physical activity (Hamlin et al. 2016). 
2.18 Prescription form background 
Medical prescription forms (symbolised by �) which may be abbreviated as Rx are instructions 
issued to a patient to acquire pharmaceuticals, prescription drugs, or to undergo a health care 
programme. The instructions govern the plan to be put in place by the prescribing clinician. 
Prescription forms may only be issued by a suitably qualified clinician. For prescriptions to be 
legal and useable, they must be authorised and signed by a qualified medical professional. 
The use of prescription forms in medicine has a long history in the field of medicine. The 
symbol � represents what medical prescriptions historically derive from, recipes. Original 
medical prescription were recipes, instruction, issued as orders from a shaman or other person 
in a community deemed to have the authority or power to heal. It is from these that we have 
the present-day doctor. An interesting area, but medical history is out of the scope of this 
review. 
In the modern day, prescription forms are well understood by patients to be instructions from 
a medical professional to acquire treatment. Prescription forms have a respected status 
amongst patients. They are also seen as confirmation by the doctor that the patient is indeed 
in need of medical attention. Therefore, patients often hope to receive a prescription when 
they see a doctor, this is certainly applicable in primary care where up to 67% of patients 
expected to receive a prescription form according to one study (Britten & Ukoumunne 1997). 
It is because of the status of prescription forms and the acknowledgment that patients in 
primary care often expect and hope to receive one, that the L� is fundamentally based, in 
design and concept, on a regular prescription form. In Wales, UK where this research was 
conducted, a standard prescription form is referred to as a WP10 by the medical community. 
In Wales, a prescription form is a WP10 as this is a bilingual version of the FP10 prescription 
form which is used in England. The WP10 was taken and used as a backbone for the design 
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of the L�. 
2.19 Lifestyle prescription 
 
The L� then is a culmination of previous research delineated in this review. The reasoning 
behind the L� stems from theory including, self-determination theory (Ryan & Deci 2000) and 
also the COM-B mode (Jackson et al. 2014). 
Although the patient is the target of the behaviour change to improve health outcomes in the 
population. The clinician is as much a target in the model due to their necessary participation 
in engaging the patient. To this end, clinician behaviour must also change with the 
development of new behaviour change theory and best practice. It is hoped that the L� will 
act as a sign post for the clinician and to remind them to have a behaviour change conversation 
with patients. It is also hoped that the use of the form will increase confidence and enhance 
the clinician’s own capability in line with the COM-B model. 
The L� also acts as a way of standardising health harming behaviour advice given to patients. 
It enables clinicians to have a talking point on the main areas necessary to change. The L� is 
kept up-to-date with the most relevant services to help patients change their behaviour, 
including the Welsh ‘Help Me Quit’ service. Furthermore, as previously found in the GRx, the 
L� is a tangible aid for giving patients guidance and goals (Hamlin et al. 2016). 
2.20 What this review adds 
 
There is little literature which fundamentally discusses the delivery of multiple behavioural 
changes such as smoking cessation, PA increase, alcohol reduction and eating a healthy diet 
in a prescriptive manner. In this regard there is a gap in the literature as there is a fundamental 
difference between advice giving and prescribing. Patients regard a prescription form in a 
different manner and with a different level of authority than they do very brief advice received 
from a clinician in a 10-minute consultation (Britten & Ukoumunne 1997). 
Furthermore, there is little literature which investigates the use of a material piece of lifestyle 
guidance to be delivered to patients and the effect of such a material on the clinician’s 
likelihood of instigating a behaviour change conversation. Behavioural change for both the 
patient and clinician is two sides of the same coin. Before patients can successful commit to 
changing their health harming behaviours it is first necessary that the clinician has the ability 
to have the behaviour change conversation and perform a brief intervention. This conversation 
may be more likely to take place if the clinician is prompted by a visual material aid such as a 
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lifestyle prescription. What’s more, a lifestyle prescription would contain the necessary advice 
which may cue to the practitioner to attend to the most necessary behaviours for the patient 
to change. This process can be explained by the COM- B model (Jackson et al. 2014) which 
explains the need for the clinician to have the capability to perform the conversation/brief 
intervention, the opportunity (such as the patient being in the 10 minute consultation) and the 
motivation to perform the brief intervention (such as improved patient outcomes, reducing the 
burden on the practice etc). 
Most present literature attests to the virtues of using motivational interviewing as well as the 
usefulness of the trans theoretical model (Prochaska & Velicer 1997) to underlie the process 
of how change is instigated (Brobeck et al. 2014). This literature review adds to the field of the 
knowledge the need for further research into the effects of prescriptive behavioural changes 
to a patient with cardiovascular disease or its risk factors. The concept of bona fide prescription 
of behavioural changes via a made-for-purpose prescription form is novel. A prescription form 
that is designed to be solely used for behavioural change intervention, which would fit within 
the context of a consultation revolving around behaviour change, may aid patients in their 
change of behaviour- focussing on ‘the big four’, smoking, physical activity, alcohol 
consumption and healthy eating. 
It is crucial that primary care practitioners are trained in behaviour change counselling. Over 
80% of the UK population consult with GPs annually, which provides the potential for 
opportunistic behaviour change advice and thus makes ‘every consultation count’ (Lawrence 
et al. 2016). Not only this but there are on average more than 5 GP consultations per person 
per year. This figure indicates many people see their GP more than once per year and 
therefore enables follow up. A study by Buttar et al. (2005) found that although the study 
primary outcome was not met (a composite measure of beneficial behaviour change at 3 
months post intervention) patients who had seen a clinician trained in behaviour change 
counselling were significantly more likely to feel they had been engaged about behaviour 
change (91.1% vs 55.0%) and also were intending to change a lifestyle behaviour (72.1% vs 
49.3%) (Buttar et al. 2005). This study provides justification for trialling a new technique in 
primary care such as the use of multiple health behaviour change leaflet in the format of a 
prescription form combined with signposted advice and services. 
2.21 Where this review leads 
This literature leads to the research study outlined in this dissertation which aimed to assess 
clinicians’ perceptions of a lifestyle prescription for use in the primary and secondary care 
setting to determine if clinicians would find it a useful tool for engaging patients in behaviour 
change. The study was justified by the finding that there is a gap in the scientific literature as 
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3.1 Initial evidence  
 
The research contained within this dissertation stems from two parallel studies conducted in 


















Figure 3. Map of Wales showing the location of the Cwm Taf University Health Board 
and surrounding health boards of Wales. 
 
CTUHB, Wales, UK (Figure 3). Both studies, labelled P-PLAC and S-PLAC, involved first the 
creation of written protocols (appendix) and ethical approval through the NHS and also the 
University of South Wales Faculty of Life Sciences and Education ethics committee. As Chief 
Investigator, I attained a good clinical practice qualification by completing the necessary 
modules. The course informed me of how to conduct healthcare research in abiding by correct 
ethical and documentary procedures. The studies also necessitated the completion of IRAS 
forms online (appendix) due to the nature of conducting research in the NHS. Both S-PLAC 




Anecdotal evidence from several clinicians determined the initial suitability for the prescription 
form to be used in a healthcare setting before the commencement of the studies and thus 
provided scope to perform a larger survey on healthcare professional’s opinions of the L� 
concept to find if they would utilise it in their own clinical practice. It was determined that the 
MRes should be made up of two parallel but separate studies to suitably elucidate the 
effectiveness of the L� in the two predominant healthcare settings, primary care and 
secondary care. 
 
Forms for the studies were created included protocols, participant information sheets, consent 
forms; these are available in the appendix. 
 
3.2 Overall recruitment  
 
For P-PLAC and S-PLAC; practitioners located in the CTUHB board were speculatively 
contacted with a letter of invitation via email asking for an expression of interest to take part 
in the study. Clinicians that indicated their wish to take part in the research were sent a 
participant information form detailing what is expected from them during the research and how 
the L� will be used during their consultation. The lead investigator arranged a visit to gain 
consent and give more information to the prospective participants. Participants signed a 
written consent form to take part in the study which informed them of their right to withdraw 
from the study at any time. Clinicians in the secondary care setting at Royal Glamorgan 
Hospital were recruited as well as practitioners in general practice in the Cwm Taf Health 
Board. The Royal Glamorgan Hospital is located in the Welsh Valleys and serves a large area 
of mixed economic structure including areas of high deprivation. The geography of the location 
was taken into account when conducting the study as the practices were spread far apart from 
one another. Participants were given 1 month to partake in the study and issue as many 
scripts, from a pad of 20, as they could within this time frame to patients which they deemed 
suitable to receive a L�. 
 
Thirty-six healthcare professionals were recruited into the study which included primary and 
secondary care clinicians of varying specialties; 18 doctors (12 secondary care of varying 
specialties and 6 general practitioners), 15 nurses, and 3 healthcare assistants in general 
practice. The full breakdown of recruited practitioners was consultant cardiologist (3), 
Consultant pulmonologist/ respiratory physician (3) cardiac rehab nurses (4) consultant 
diabetologists (2) registrar diabetologist (1) general physician (2) preoperative nurse (1) heart 
failure nurse (2) consultant geriatrician (1) general practitioner (6), nurse practitioner (8), 
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healthcare assistant (3). 
 
3.3 The desktop pad development 
 
The L� pads were printed professionally in colour with 20 sheets to a pad. The pad was 
designed to be used on a GP’s desktop or on an outpatient clinic desk. The pad was developed 
















3.31 L� development 
 
Figure 4. The L� form. 
 
The L� (Figure 4 ) was developed by Public Health Wales with other  
stakeholders including the Cwm Taf University Health Board. The material is novel in its 
multiple health harming behaviour change advice as well as up-to-date signposting to local 
services. Crucially, the script was designed to emulate a bonafide prescription form (WP-10) 
which is signed by prescriber as well as the patient receiving it. The design and creation of the 
L� was commissioned by Public Health Wales with input from multiple organisations and 
practitioners including GPs, Cwm Taf Public Health Team, Wales Centre for Behaviour Change 
(Bangor University), dieticians, Psychologists, Nurses, Communities First Work Club, 
Caerphilly Cohort findings and current guidance.  
 
During the course of the study the L� script was developed further to make it more suitable 
for use by the varied specialties of participants which used the script. Each L� was allocated 
a different version number. “As your doctor” was changed to “As your prescriber” to enable 
the L� to be used by clinicians other than doctors. Also, on traditional prescription forms the 




A standard prescription form does not have to be signed by the patient. It is only signed by the 
prescriber. The L� is signed by the patient too as this forms a key part of the ‘behavioural 
contract’ which the L� is trying to instigate. 
 
Before the study commenced the L� was also updated to display up-to-date contact 
information for the services which are listed on the back. This was primarily because Stop 
Smoking Wales was merged into a service called Help Me Quit. Wording of the advice which 
is given on the L� was updated to appeal to a broader audience and not be deemed too 
paternalistic. 
 
The back of the L� pad contained a section which displayed advice for the participant to use 
(Figure 5). This information was created to guide the clinician in their use of the L� and also 
to act as a prompt for them to undertake a behaviour change intervention. 
 
 
Figure 5. Back of the L℞ pad containing advice for clinician. 
3.32 Log form 
 
A log form (Figure 6) was created and integrated into the L� pad. This was to be used by the 
participants of the studies to collect data on the reason for issue of an L� script as well as 
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anonymous demographic data on the patient it was issued to. With consultation with the 
healthcare professionals and public health wales we developed a log form to capture the key 
data applicable to the study to enable accurate assessment of how the L� was utilised. 
 
Figure 6. The L� participant log form. 
 
The log form contained cells for the participant to collect patient data such as; Age; Sex; If the 
patient was seen in the ward  (W) or outpatient setting (O); the advice given to the patient 
(smoking, alcohol use, diet, exercise); why the L� was issued ( either responding to a request 
for advice from the patient); as an alternative to prescribing medication; used as an adjunct to 





For the P-PLAC arm of the study general practices were speculatively contacted by email or 
by site visit to ask for their participation in the study. 26 practices in total were contacted of 
which 6 practices engaged and requested to join the study with a total of 18 participants.  
 
The initial research into conducting the P-PLAC arm of this research consisted of attending 
primary care practices within the Cwm Taf health board to gauge their interest in taking part in 
the research. Visiting practices enabled us to speak with general practitioners and nurse 
practitioners, as well as the practice managers, to assess the feasibility of conducting the 
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research at these premises.  
 
Most interactions were positive about taking part and the initial response to the concept of the 
L� was often met with curiosity and intrigue as well as a willingness to use it. The visits, 
although informal, enabled us to gather verbal feedback and determine the most suitable way 
of conducting the research in the primary care setting in the Welsh Valleys.  
 
Due to the nature of the study and the logistics involved in recruitment, the Research and 
Development department at the Royal Glamorgan Hospital were actively involved in helping 
to recruit for the project and engage clinicians.  
 
3.5 S-PLAC  
 
The S-PLAC arm of the research study commenced around 2 months later than the P-PLAC 
arm. This was to enable the development of a separate and specific protocol and to gain 
ethical approval from both the NHS and also the USW faculty ethics committee. 
 
I gave a presentation at the Royal Glamorgan Hospital (RGH) to make clinicians aware of the 
study and give an overview of the L� form and why it was being developed and trialled. The 
presentation received favourable feedback and enhanced the participant recruitment of the 
study. 
 
Regular visits were made to the RGH to recruit clinicians. Naturally, it was a difficult task to 
recruit very busy clinicians and therefore much time was spent trying to do this.  
 
As part of my education in the workings of the secondary care system I spent time in clinic 
with a Consultant Cardiologist. This informed me further of how a tool such as the L� could fit 
in to an outpatient setting in secondary care and how it may be used. I also sat in consultations 
where the same cardiologist prescribed the L� and from this I was able to receive direct verbal 
feedback on the ease of use of the L� and how it could be improved. 
 
3.6 Survey development 
 
A questionnaire was developed to canvass the opinions of the participants in primary and 
secondary care which took part in the study. The questionnaire was developed alongside 
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Professor Mark Williams, and also the Public Health Wales Consultant in Public Health Ashley 
Gould. The questionnaire was designed to assess clinicians opinion of the LRx, who regularly 
consult with patients with multiple health harming behaviours, including  their likelihood of 
utilising it and their thoughts on its appropriateness. The questionnaire was administered via 
the online service, Bristol Online Surveys (onlinesurveys.ac.uk).  
 
The questionnaire gave the participant a list of statements and asked them to select an answer 
of 1-5 based on the Likert scale. 1 indicated strongly disagree, 2 disagree, 3 neutral, 4 agree, 
5 strongly agree. 
 
A questionnaire was used as this was the most efficient way of obtaining feedback from 
clinicians with little time to spare during their working hours. The questionnaire enabled the 
acquisition of feedback on the LRx which was adequately detailed to inform its further 
development. 
 
A Likert scale was used to obtain clinician feedback as this was deemed the most appropriate 
method of capturing data of these items in questionnaire format considering the novel items 
which were being used. The questionnaire also contained a free text element to enable 
clinicians to enter their own feedback. A 5-point Likert scale was used which gave the 
participant the option of a ‘neutral’ value. A neutral value was perceived as being positive in 
the dichotomous analysis of the results. This was due to the assumption that participants who 
felt neutral about the LRx would probably not be averse to it’s use or place in the medical 
setting. It is also known that participants tend to choose the extremes when a Likert scale is 
used to collect survey information.  
 
The questions used in the survey were developed with input from the academic study team 
and were developed to gain useful feedback on clinician’s perception of the LRx. A similar 
questionnaire had not been previously developed due to the uniqueness of the resource which 
as being examined. This necessitated the development of a questionnaire with items never 
previously used in qualitative research, to the author’s and study team’s knowledge. 
 
The questionnaires can be found in separate files linked to the appendix. 
 
 




P-PLAC and S-PLAC were approved by the Faculty Research Ethics Committee, University 
of South Wales. The studies received a favourable review by the Cwm Taf University Health 






All statistical analysis was made using SPSS (IBM SPSS Statistics for Apple Mac, Version 14, 
Armonk USA) with statistical significance defined p <0.05. Comparisons between groups, 
including primary care and secondary care and doctors and nurses, were made using the non-
parametric Mann Whitney test. A chi squared test was used to assess significance between 







Overall, twenty-three participants completed both the end of study questionnaire and the log 
form (64% completion) (figure 7).
 
Figure 7. Flow chart illustrating participant outcome 
 
The number of L� prescribed by each participant varied widely from 0 to the maximum of 20. 
This data was obtained from the log form which was completed by the participant. The mean 
age to which an L� was prescribed was 56 years (range 35 - 75 years). The mean percentage 
of L� prescribed by a participant was 41% (CI 29-55%).  
 
The results are stratified into the two arms of the study; primary care and secondary care. 
Participants recorded on the log form the advice they gave to the patient with the use of the 
L� as well as the reason for prescribing the form from a choice of; responding to request for 
advice, as an adjunct to prescribing medication, as an alternative to prescribing medication or 
alongside a referral. There was no restriction on the number of reasons to which the form was 




4.1 Prescription distribution in Primary Care 
 
In PC, 11 participants distributed 108 LRx forms from a possible 240 (45%) to patients (mean 
age 53 years, range 35-66 years, Male:Female 57:43 %). 22% of the LRx were prescribed to 
patients with established heart disease. The mean percentage for prescribing each lifestyle 
change were as follows; dietary (62%), physical activity advice (61%), smoking advice (48%), 
alcohol advice (25%), The mean percentage for each reason for issuing an LRx was as 
follows; 51% as an adjunct to prescribing medication, 46% LRx issued in response to a request 
for advice from the patient, 14% as an alternative to prescribing medication, 3% alongside a 
referral to SC.In the Primary Care arm 12 participants distributed 108 L� forms from a possible 
240 (45% prescribed). The mean age of the patients for which the L� was prescribed was 53 
years (range 35-66 years).  
 
 
4.2 Prescription distribution in Secondary Care 
 
In SC, 12 participants distributed 88 LRx forms from a possible 240 (37%) to patients (mean 
age 60 years, range 48-75 years, Male:Female 68:32 %). 55% of the LRx were prescribed to 
patients with established heart disease. More LRx were prescribed in clinic/outpatient settings 
than in the ward setting; mean 80% clinic, mean 20% ward. The mean percentage for 
prescribing each lifestyle change were as follows; diet (69%), exercise (64%), alcohol advice 
(38%), smoking advice (36%). The mean percentage for each reason for issuing an LRx was 
as follows; 34% LRx issued in response to a request for advice from the patient, 34% as an 








Completed questionnaires and log forms were received from 11 primary care and 12 
secondary care participants, respectively (Table 1).   
 
Table 1. Showing the percentage participant responses to the survey questions. 
 
 
There was no significant difference, between primary care and secondary care, of the 
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number of L� used or of the mean age prescribed to (P >0.05). There was also no 
significant difference in the number prescribed to males or females between primary 
and secondary care (P > 0.05). However, in secondary care more L� were prescribed 
to males than females which was significantly different (p=.017). There was no 
significant difference within primary care (P >0.05). The reasons for issue for both 
primary and secondary care groups are shown (Table 2).
 
Table 2. Showing the average percentage for the reason of issue of the L�. 
 
No differences were found between the prescribing habits of doctors or nurses across all 
examined variables except the variable ‘prescribed the L� in response to request from advice 
from the patient’ p=.006. Nurses and healthcare assistants were significantly more likely to 
tick this option on the L� log form. 
 
Comparisons were made between nurses and healthcare assistants (15) and doctors (8) of 
the questionnaire responses. There was a significant difference between the response to the 
question ‘most of the time, I had adequate time to deliver the L� to patients alongside giving 
verbal advice’ (p = 0.12) as doctors were more likely to disagree or strongly disagree.  
4.4 Qualitative Feedback via the questionnaire 
 
Participants were able to leave feedback at the end of the questionnaire. The last part of the 
questionnaire requested, “Please give any comments or thoughts you have on the lifestyle 
prescription form. Any at all!” The qualitative data was assessed by the study team and is 
being used to further develop the L� outside of the scope of this MRes. 
 
“I think it's a good idea.  I didn't give many out during the study period for a mixture of reasons 
- many patients needed investigations or medication prescribing, and I felt going through this 
too would be too much.  A larger proportion of patients than I expected had severe pathology 
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which lifestyle changes wouldn't help with.  I would be happy to have them in my clinic room 
and use them when needed.  It was useful to have the contact numbers etc all there on one 
document, though I don't think the patients took the "prescription" idea well.” 
 
“Apologies as I was unable to use any due to the short study window and lack of suitable 
patients.” 
 
“1 patient was not willing to have a lifestyle prescription - probably this attitude reflects his 
general attitude towards medical advice.  It will be great if there is a commitment from both 
sides doctors and patients for follow up shortly after the prescription is given.” 
 
“A useful resource.  I would have liked more time to utilise them.” 
 
“Well laid out and clear. Wish I had more time to trial this properly.” 
 
“I think this is a good way to back up advice given to specific patients. However, on reflection 
our patient group were not ideal for this study.” 
 
“The study ended before I had enough opportunity to further my opinion of their usage. Can 
see they would have a useful place in cardiac rehab, as it mirrors the advice we discuss with 
the majority of our patients.” 
 
“Suggest make it more patient centred with up to date information on the back.” 
 
“Patients seemed to respond to the quit smoking aspect of the lifestyle prescription form.  It 
gave them more confidence to go into a pharmacy and ask for help.” 
 
“I thought the script was a good way to enable patients to make decisions about their own 
health and to consider making changes. It was accepted well as given reasons for change and 
how they could get support” 
 
“Good to have information all on one sheet.” 
 
“Visually very clear leaflets.” 
 




“Carbon copy for notes.  Add diabetic advice.” 
 
“I already give advice on everything included as part of the education I provide for patients.” 
 
“I used the form as a 'preoperative prescription' which seemed to help. It would be helpful if 
the form could be modified to reflect this. If this is not practical, I would happily use the form 
as it is!” 
 
“Unfortunately, I didn't get around to using it in the time frame which was largely due to having 
to carry the pad around with me prior to attending clinic.  I think the idea of increasing 
awareness of lifestyle therapies is a good one.  I'm not sure it is necessary to make the patient 
sign, as we wouldn't ask patients to sign for any other type of therapy or prescription and this 
may make them feel coerced or pressured.  The information on the reverse is useful.” 
 
“The form itself is very good. I think my 'problem' is that I'm inclined to talk a lot to patients and 
giving out information is somewhat secondary. I suspect others used it more usefully than I 
did.” 
 
“At first I was worried that the patients would feel patronised by the lifestyle prescription.  They 
actually welcomed it and I think that the information and links on the reverse of the script is 
excellent and an aid to motivation.  I would be interested to find out how many times lifestyle 
advice needs to be reiterated before it is acted on, or if it is more to do with the delivery from 







This is the first study, to the author’s knowledge, evaluating a novel ‘lifestyle change 
prescription’ specifically designed to provide guidance to patients and to prompt clinicians to 
engage patients in behaviour change and is the first to determine medical practitioners’ 
perceptions of such a material tool for use in the medical setting. 
The results of this study indicate that clinicians are in favour of an L� for giving advice to 
patients on changing health harming behaviour. Recruited participants were mostly positive 
about the L� concept but some cited lack of time as the main issue for lack of using the L� in 
consultation. The concept of lack of time for issuing lifestyle or behaviour change advice is a 
common theme throughout the behaviour change literature when considering the clinicians 
role in delivering such advice (Elwell et al. 2013). Doctors were more likely to cite lack of time 
than nurses in using the L�. This is in line with multiple studies which illustrate lack of time as 
a main barrier to clinicians engaging their patients in lifestyle change (Lawlor et al. 2000; 
Jansink & Braspenning 2010). 
Some participants cited little use of the L� during the study due to the “short study window” of 
1 month. It was deemed that 1 month should be suitable for most clinicians to administer up 
to 20 L� taking into account the usually high number of patients that a clinician consults with 
on a daily basis and the likelihood of any given patient requiring lifestyle advice, which is high. 
Britten et al (1997) previously found that a large percentage of patients expect to receive a 
prescription form when in the primary care setting. In fact, 67% of patients hoped to receive a 
prescription form from their GP. Nevertheless, in this same study 25% of patients hoped for a 
prescription form but did not receive one. Taking this study into account, the L� can be utilised 
to fill the gap for patients who wish to receive a prescription but are deemed not suitable to 
receive a pharmacological prescription. A clinician is able to provide an L� alongside giving 
verbal advice to most patients that present to general practice or secondary care. The L� may 
be an aid in taking pressure of clinicians who feel they need to prescribe because the patient 
wishes to leave a consultation with something tangible (Britten & Ukoumunne 1997). 
Management of cardiovascular risk includes adoption of healthy lifestyles. However, uptake 
and completion rates for lifestyle programmes are low and many barriers to lifestyle behaviour 
change have been reported in the literature (Jarbøl et al. 2017). Therefore, the L� proposes 
a way for practitioners to engage their patients in a conversation around behaviour change, in 
a brief intervention format. The L� is based on the self-efficacy model of self-determination 
theory Ryan & Deci (2000) which proposes a model which highlights the importance of the 
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human evolved and necessary inner or ‘intrinsic’ motivation and drive for growth and 
development. The L� suitably capitalises in self-determination theory by giving the patient the 
resources (tools) to take initiative and act upon for their own wellbeing whilst encouraged to 
do so by the healthcare professional. 
For the patient population to be willing to make behavioural lifestyle changes, it may be first 
necessary for the healthcare practitioners to have ‘bought in’ to the idea of practicing behaviour 
change interventions and to see it as their responsibility and duty to initiate behaviour change 
to reduce health harming behaviours in their patients (Kaner & McGovern 2013) .This study 
has determined that practitioners are willing to engage with the concept of ‘prescribing’ lifestyle 
advice and are happy to issue it to patients with health harming behaviours in a prescriptive 
manner. 
More scripts were used in the clinic setting than the ward in secondary care. Likewise, more 
scripts were issued in primary care. This may reflect the L� suitability in a desk-based 
consultation setting as opposed to use on the wards where practitioners are more mobile and 
may be preoccupied with many more tasks, patients and distractions. As the L� is a 
prescription-based material with the intention of delivering lifestyle instruction and information, 
it may be more suitably applied to consultations where the patient is able to engage with the 
clinician in a private and more focussed environment as opposed to a busy ward setting. The 
L� may be well suited for use in outpatient clinics run by consultants in this same manner. 
The L� can be viewed from a COM-B perspective, that is; capability, opportunity and 
motivation which are intertwined to formulate the behavioural outcome. Healthcare 
practitioners have the capability to deliver accurate and consistent lifestyle advice to their 
patients from an academic and empathetic perspective. They also have the opportunity to 
instigate behaviour change in their patients by providing a brief intervention during a 
consultation and giving lifestyle advice exploiting their valued position in society as healthcare 
professionals. There should also be a motivation for practitioners to give lifestyle advice taking 
into account the massively detrimental effect that health harming behaviours have upon 
patient’s health and the large proportion of the burden of disease as a direct result. Reducing 
the burden on the healthcare service is a benefit that cannot be overstated, it starts with 
prevention. 
A benefit to this study was the good amount of heterogeneity in the participants as well as 
good heterogeneity in the patients in which the script was issued. 




A predominant reason for the initial development of the L� was that there currently existed no 
suitable, desk based, material tool that was useful for the patient in instigating behaviour 
change and also of benefit to the clinician in acting as a prompt or nudge for them to undertake 
a behaviour change conversation with their patients. 
As the L� was developed and commissioned by Public Health Wales, this was a key factor in 
its creation. It is an aim of Public Health to work towards making every consultation count 
(MECC) and the L� was thought of as a tool which could potentially help clinicians’ edge 
further towards this goal. 
Naturally, for this to be able to take place, clinicians must see value in the tool itself, be 
comfortable with using it and be content for it to take a place on their desk. If the L� is not 
placed in view on a clinician’s desk then its purpose becomes basically defunct. 
The results from the questionnaire were generally positive about the use of the L�. the L� 
appeared to be especially valued by nurses and healthcare assistant according to both the 
free text comments of the questionnaire and also the Likert scale results. 
 
5.02 Use of L� by doctors and nurses plus healthcare assistants   
 
As nurses were more likely to report positively about the L� it is speculated that this may in 
part be due to the increased availability of time which they may have in their consultations with 
patients(Jallinoja et al., 2007). The nurses recruited into this study were also specialised, 
including heart failure nurses, cardiac rehabilitation nurses and general nurse practitioners. 
Not only may these nurses have more time to dedicate to the issue of lifestyle advice but it is 
a common part of their daily consultations with patients and they are often more trained than 
doctors for this purpose. 




It could be said that the L� medicalises behaviour change while also medicalising the solution 
to a patient’s health harming behaviours. Medicalisation in the sense that the advice is being 
issued in a prescriptive and perhaps authoritarian manner. Nevertheless, taking the success 
of the GRx into account, this may be an effective mechanism of action for changing behaviour 
56 
 
in specific patient groups. It is known that healthcare professionals instructions are viewed 
differently by the different societal strata. People of lower socio-economic class with low levels 
of health literacy may benefit most from an instructionalist paradigm of health promotion (Yin 
et al. 2012). A negative aspect of prescribing lifestyle advice could be the perception of 
medicalisation of lifestyle guidance rather than viewing it as a counselling methodology. 
However, if the predominant target of lifestyle advice is to those of low socioeconomic class 
with low health literacy but also an environment which promotes health harming behaviour, 
medicalisation may have a small effect on changing behaviour. Furthermore, those of low 
socioeconomic class often reside in areas where there are fewer opportunities to purchase 
high quality produce or engage in physical pursuits (Handy et al. 2002). 
5.12 Advice 
 
The L� is simply advice. It is advice issued in prescriptive form and printed on a leaflet. 
However, the way the advice is issued to the patient, verbally, is equally as important as the 
format in which the patient takes it away (Brobeck et al. 2014). It may be necessary that all 
clinicians who utilise an L� are appropriately trained in the motivational interviewing technique 
to enable them to best convey behaviour change information to patients and to have better 
success (Lee et al. 2016). 
5.13 Personalisation 
 
The L� lacks any kind of personalisation which is unusual in the changing world of medicine 
becoming increasingly personalised. It is also paradoxical that the L� is based on a 
prescription form but is then not personalised to the patient. Personalised medicine has shown 
to be more successful and this may be applied to changing behaviour. The L� does not enable 
a patient to receive access to any sort of behaviour change treatment, it does signpost to 
services that can help. However, the patient has to take responsibility for this and must initiate 
contact. This may work for patients with high levels of self-efficacy and high motivation but 
may not work for those without or other perceived psychological barriers. 
5.14 Paternalistic 
 
One participant in the primary care arm of the study remarked that he found the L� to be 
‘paternalistic’ and felt uncomfortable issuing many. This may be because of the medicalisation 
aspect of giving simply lifestyle advice or, as other participants reported, that having the patient 
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sign the script when prescribed is an unusual methodology (Brandling & House 2009). 
Perhaps the L� in its current format could be seen as taking the humanity out of a consultation 
between the patient and clinician. 
The format of the L� is also quite different to the general stance of today’s health service when 
it comes to generating treatments with a patient. In the current health service and certainly in 
primary care, treatments are tailored to the individual need considering the patient’s personal 
psychosocial health requirements whilst acknowledging their explicit health needs. Thus, the 
L� takes a different view on how treat patients afflicted with health harming behaviours and 
works on a historical healthcare model, one that is more authoritarian and contractual than 
autonomous and individualised. 
5.15 Goal oriented 
 
The L� is not designed to be a goal-oriented instrument for the patient. Goal oriented 
behaviour change has been found to be some of the most successful types of behaviour 
change techniques available (Michie et al. 2005). It is not certain where the L� fits into the 
behaviour change taxonomy developed by Michie et al. It may be that the LR does not actually 
fit into the current model of behaviour change taxonomy because it is not fundamentally for 
the patient. It appears that the L� is in fact designed with the clinician in mind and in a sense, 
aims to change the clinician’s behaviour as far as it can promote the clinician conversing with 
the patient about health harming behaviours. In this regard the L� is still a tool designed to 
change behaviour, but perhaps not that of the patient but the consulting clinician. 
5.16 Dependent on practitioner ‘buy in’ 
 
Taking the former points into account, the L� will only be a successful tool if it is appreciated 
by the clinician enough to warrant its place upon the desktop and also for the clinician to feel 
the information contained within the script is of value to the patient. 
If the tool is seen as having value to the clinician in that it provides an easier route of conveying 
lifestyle advice; it reduces the burden of having to spend much time communicating to the 
patient the value of changing behaviour; or it minimalises the mass of paperwork in leaflet 
form required to direct patients to community services, then it may be successful at attracting 
the clinician to its use. 
If the L� achieves this for the clinician, then it has fulfilled its primary duty and in theory should 
promote more behaviour change conversations taking place in the consultation room. 
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5.17 Population approach to behaviour change 
 
The underlying message of the L� to the primary or secondary healthcare provider is that it is 
their duty to give lifestyle advice to patients and to aim to initiate behaviour change. However, 
it is not clear that doing so will cause behaviour change to take place (Elwell et al. 2013). 
Furthermore, general practitioners have expressed concern for adopting a population 
approach to behaviour change. A main concern being the possible detrimental effects on the 
doctor-patient relationship of providing lifestyle advice to all patients (Lawlor et al. 2000). 
5.2 Limitations of the study 
A limitation to this study was the small sample size of participants. The main reason being that 
the study was based in a single Welsh health board and recruitment of clinicians was difficult 
and logistically awkward. It was envisaged that the study could move into the Cardiff and Vale 
health board to increase participants numbers whilst also taking into account the different 
demographic characteristics which exist in this health board compared to the CTUHB. In 
hindsight, the study itself should have run for longer to enable participants to have more time 
with the L� script. A number of participants said they did not feel they had enough time in the 
study to prescribe the L� and get a good feel for the use of the L�. However, it could be 
speculated that this maybe a reflection of practitioners feeling many patients were unsuitable 
to receive the script therefore they didn’t have enough time to find suitable patients. It is also 
possible that practitioners used lack of time as a cover up reason for not prescribing the L�, 
they may have felt that it wasn’t suitable for their patient or they may have lacked the 
confidence to use it. Nevertheless, the majority of participants reported feeling confident in 
giving lifestyle advice to patients and most said that prior to the study they had frequently given 
lifestyle advice. Only one hospital was trialled in delivering the L� but this hospital serves a 
wide range of social demographics including the lower socio-economic class of the South 
Wales Valleys. There was no control group in this study as this was not suitable due to the 
methodology of testing the L�. The study did not assess whether or not a material tool such 
as the L� was useful in promoting the likelihood of the clinician engaging patients in behaviour 
change which should certainly be a critical assessment point if there is to be continued 
research and development of this tool. 
Another limitation discussed at length during the viva voce for this MRes was the use of the 
survey and Likert scale to answer the research question. In hindsight, more appropriate 
methods for qualitative assessment would have included interviews and/or focus groups for 
to analyse perceptions of the LRx. However, as discussed at the viva, time and resources 
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The findings from this study indicate that some clinicians may find an L� useful in aiding their 
usual verbal advice to patients with health harming behaviours. From a COM-B perspective 
the L� provides the practitioner the capability to give reasonable and up-to-date advice 
regarding health harming behaviours as well as signposting the patient to useful services that 
can continue to engage them in changing their behaviour. This may be enough in itself to 
justify the use of the L� as it could save time in distributing important up-to-date information 
to patients as well as reduce the number of resources needed to be dedicated to lifestyle 
guidance. The L�’s clear and compact format make it suitable to be distributed in many 
healthcare settings. 
The L� may be viewed as being a glorified leaflet. In many ways this presumption would be 
correct. The L� does contain a novel method of ’solidifying’ advice to the patient via the co-
signing feature but this may be seen as a potentially unnecessary to the patient or worse 
disconcerting. The L� at its most fundamental is a material which simply outlines several 
services which a patient is able to contact if they so choose to aid them in changing their health 
harming behaviours. It does this and no more. Yet, for all the L� lacks in usefulness, it may 
make up for if it is suitably able to increase the likelihood of clinicians engaging patients in a 
behaviour change conversation. 
The L� must be trialled on a patient group in a randomised setting to determine whether 
patients would follow up on the advice issued to them via the medium of this novel prescription. 
It should also be determined if the presence of the L� in the clinician’s consultation increases 





7.0 Future Direction 
The L� is similar to the New Zealand initiative of ‘Green Prescribing’ but different in its 
mechanism of action (Clay 2001). Green prescriptions (GRx) were developed for use in the 
New Zealand primary care setting and are managed by the New Zealand ministry of health. 
The GRx has suitably capitalised on the power of the prescription format, which has respect 
from patients and is valued. Patients also see prescription forms as serious written orders from 
a clinician. Therefore, the prescription format is a powerful medium to convey lifestyle change 
advice to patients. The L� is similar in this fashion as it also utilises the prescriptive 
methodology. However, where the GRx links patients to services that will help them on their 
behaviour change journey, the L� simply gives patients information, not unlike a simple leaflet 
one would pick up from a general practice reception, and then leaves the patient to their own 
devices. It is unknown whether this would lead to effective and lasting behaviour change, or 
even if it will lead to a behaviour change attempt (Coulter & Ellins 2007). 
Therefore, I recommend that the L� move towards a framework analogous to the New Zealand 
GRx. This method of function would suitably enable the prescribing clinician to track the 
patients behaviour change progress in their lifestyle modifications. There may potential for the 
L� to be attached to the Welsh National Exercise Referral Scheme (NERS) (“National 
Exercise Referral Scheme (NERS) - WLGA” n.d.) and to expand on the limitations of this 
scheme at present to provide a more holistic behaviour change service. The NERS scheme 
has secured funding from the Welsh Government until March 2019 therefore there may be 
scope to design a behaviour change programme with broader horizons than the current model. 
It is necessary to assess whether material tools such as the L� are able to influence the 
likelihood of medical practitioners having behaviour change conversations with patients 
regarding lifestyle behaviours. The key to the L� having any effectiveness is it’s use by the 
prescribing clinician. Therefore, the foremost behaviour change lies with the prescriber. I found 
no suitable literature which attests to the usefulness of any material tool in helping to improve 
the likelihood of behaviour change conversations taking place. I believe this area of research 
to be lucrative in determining what is useful in a behaviour change context. 
Evidence suggests that brief interventions are useful in changing patient behaviour. Taking 
this into account, increasing the amount of such conversations/ interventions taking place the 
greater number of successful behaviour change attempts will happen thus reducing the 
amount of health harming behaviour in the population. 
The L� may be developed further with the social prescribing model in mind (Brandling & House 
2009). The concept of co-signing could be useful in engaging patients to actively engage with 
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social prescriptions including community engagement, exercise classes or even breastfeeding 
clubs for young mothers in socially deprived areas, like Cwm Taf. However, it isn’t known how 
successful such ‘social contacts’ would be even with the co-signing of prescriber and patient 
in place. I believe care should also be taken to avoid “parternalising” or medicalising every 
aspect of someone’s life because of their social class. Nevertheless, the ideas may warrant 
exploration. 
As this study found that nurses adapted to the use of the L� more successfully than many of 
the doctors it may be useful to develop nurse specific and doctor specific L�. It would be 
important to find out the differences that these groups would appreciate in the L� form itself 
and if they would utilise it differently. Nurses may appreciate the L� as it is a tool which they 
can ‘prescribe’ and thus express more authority to the patient whilst still not having to take 
responsibility for pharmacological prescriptions which requires greater responsibility. 
Naturally, a crucial next step in the development of the L� is attaining feedback from patients 
on the concept and usefulness of the script from the patient point of view. The result of this 
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9.1 Public Health Australia Conference 
 
As I was privileged to be able to attend the national conference for the Public Health 
Association of Australia in Cairns, Australia September 26th to 28th I am dedicating a chapter 
in this dissertation to briefly compare and contrast the health inequities that exist in Wales and 
Australia and the impact of these inequities on cardiovascular morbidity. A researcher and 
clinician whom I very much admire, Sir Professor Michael Marmot has written extensively 
about these matters and has worked across many disciplines relating to the social 
determinants of health. Prof Marmot is British born but moved to Sydney when young and was 
educated their and later in California. Reading his book ‘The Health Gap’ just before I 
commenced this MRes really enthused me about Public Health and made me feel like action 
needed to be taken. It was by chance that I found this MRes which was well suited to my 
newfound interest in health inequality and public health.  
 
I was fortunate to attend a talk by Prof Marmot held in Cardiff shortly after commencing my 
MRes. The talk he gave was motivating and positive. I became aware that there is much that 
we can do as a society to make things fairer and thus improve health for everyone. 
 
Australia and Wales have some similarities in their population demographics with both 
countries having large populations of white Caucasians and both of these populations 
stemming from the British Isles. However, there are stark contrasts as Australia’s population 
is approximately 25,088,296 as of September 30th 2018 (Australian Bureau of Statistics, 2018) 
and the population of Wales, UK is estimated to be 3,125,000 as of the 30th June 2017 (The 
Welsh Government, 2017b). Furthermore, Australia has since the 1950s seen many different 
waves of immigration from various other countries other than the British Isles. Predominantly, 
Italy, Greece, India, China, Vietnam, Korea and Indonesia. The Asian migrations have been 
more recent due to the infamous ‘White Australia’ Policy that the government had in place until 
just a few decades ago. As well as this, Australia was home to its indigenous peoples for 
around 60,000 years before the British landed on its shores in Botany Bay in 1788.  
 
The Health care provided in Australia is some of the best in the world and Australians also 
have some of the best health in the world, including the 4th highest life expectancy for males 
and females combined, the UK is 20th according to the World Health Organisation. Medicare 
is the public arm of the healthcare provision to which all Australian permanent residents and 
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citizens, and some other groups, are entitled to. However, most Australians also take out 
private health insurance and this is actually encouraged by the Government as some services 
are not free, such as transport by Ambulance. 
 
The indigenous people of Australia experience the most disparate health compared to the rest 
of the Australian population. They suffer from very high rates of cardiovascular disease, 
diabetes and other metabolic conditions. The health of those indigenous people whom live in 
the rural parts of Australia suffer the most.  Accordingly, the indigenous population have high 
rates of unemployment and many social problems such as alcoholism, drug use and other 
addictions such as gambling. These problems are historical and can easily be traced back to 
the destruction of the aboriginal culture and way of life and their systematic subjugation and 
forced assimilation by the Caucasian population. Since the times of aboriginal community 
destruction, the health of the aboriginal people has drastically deteriorated. It is not simply that 
this race of people have worse health than others. There is no evidence to say that the health 
of aboriginal people was dire before colonisation. It is clear that colonisation leading to the 
most brutal inequality served to rack the health of these people. 
 
To compare to the health of the people residing in Merthyr Tydfil and Rhondda Cynon Taf 
served by the CTUHB to aboriginal people in Australia may seem ludicrous on first inspection 
but is logical when explored. The health of those in this part of the Welsh Valleys is the worst 
in all of Wales, with high rates of cardiovascular disease and diabetes. Likewise, this part of 
Wales suffers from high rates of unemployment and social problems including addiction.  
 
The reasons for the inequality that have been experienced by the Welsh and by the indigenous 
people of Australia are also similar. Both these people experienced the attempted eradication 
of their culture by the British (English in the case of the Welsh). Both were forced to speak 
only English and not use their native languages. Both had their home lands exploited and used 
for financial gain. Granted, the history of interaction between English peoples and Welsh 
peoples stretches further back, but it seems apparent that due to recent history and the 
economic policies imposed on Wales by an English government, they have suffered.  
 
The inequality and dire health experienced by people particularly in the Welsh valleys stems 
from the destruction of their industry without any particular concern to the after effects of its 
dismantling. This area of Wales was economically dependent on the mining industry, which 
had many issues but was nevertheless the crux of life in this area. Policies enacted primarily 
by the Thatcher government saw to the end of this way of life for these people and can be 
viewed historically as having no regard to the outcome of this. Since that time, the valleys 
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have struggled to recover, and we can see today the effects on the people’s health and the 
generational link.  
 
I could write at length of the similarities between the indigenous peoples suffering and those 
of the Welsh residing in the Welsh valleys. What it comes down to is clear and well elucidated 
by Michael Marmot. Inequality kills. Inequality causes unnecessary suffering. The effects of 
inequality travel down generations and thus cause suffering even to the unborn. It is wicked.  
 
I feel I should add to this chapter that I do not believe that something such as a lifestyle 
prescription form (LRx) would be much use in the circumstances of improving aboriginal health 
in Australia. In fact, that would seem a very simplistic approach to such a convoluted problem 
entangled in culture and social circumstances. I suppose, if I do not think that the LRx would 
be of much use in aboriginal communities, then why should I believe it would be of use in 
communities of markedly disparate health in Wales.    
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The Public Health Association of Australia (PHAA) is recognised as the principal non-
government organisation for public health in Australia and works to promote the health and 
well-being of all Australians. The Association seeks better population health outcomes based 
on prevention, the social determinants of health and equity principles. (Extract taken from the 
PHAA website, a good summary of what the organisation is). 
 
I was very fortunate to attend the national Public Health Association of Australia's annual 
conference in Cairns, Queensland, Australia in September 2018. I was able to attend this 
conference due to the generous stiped budget from my KESS 2 scholarship from the 
University of South Wales, UK (not the University of New South Wales, Aus, which frequently 
confused my new acquaintances). 
 
The conference was a 3-day event held at the Pullman hotel in Cairns and was a large event 
with delegates coming from all over Australia. I didn’t meet anyone else that had flown in from 
abroad for the conference, but many people were from different nations and were now working 
or studying in Australia, so the conference had a multinational feel to it and everyone was 
there because of their passion for Public Health.   
 
Overall, the main theme was leadership in Public Health, but I found that to be a bit vague and 
not very clear as to what some speakers were calling for other than simply more leadership – 
I left some talks wanting a more concrete call to action. However, other big points that were 
covered concerned climate change and aboriginal health. I found these to be far more 
interesting and well-defined topics. 
 
Day 1.  
 
The main theme for this year’s conference was leadership in public health. Therefore, it was 
apt that one of the speakers for the opening plenary was a retired Australian Navy admiral 
who had since set up a PTSD charity for New Zealand and Australian veterans. His aim with 
the charity was to connect existing organisations dotted around Australia and New Zealand to 
provide better care for ex-servicemen and women. Another speaker in the opening plenary 
was Dr Linda Selvey who had a very interesting background including having been the CEO 
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of Greenpeace from 05 to 11. Dr Selvey was also a medical doctor and moved into public 
health. The overarching narrative in the opening plenary was the call for greater leadership in 
the Public Health community. Mrs Jeanie Beatie spoke about the importance of aboriginal 
leadership in their own communities and having the autonomy to make their own decisions for 
their own wellbeing.  
 
I noted early on in the conference that before anyone gave a talk or presentation they would 
pay respect to the original owners of the land and acknowledge their elders past and present. 
As well as this there was a ‘Welcome to Country’ talk given which I was told ‘is protocol’ and 
is the done thing when people visit different parts of aboriginal land in Australia.  
 
The second plenary after lunch consisted of talks from PhD students involved in research to 
do with aboriginal culture and the importance of this in determining health. A comparison was 
made between those aboriginal 'rangers' who were regularly out 'in country' and those that 
were not rangers. it was found that rangers had better health outcomes than did non-rangers. 
The speculated reason for this was that rangers were more in touch with their culture by being 
out on country and were experiencing a life more similar to their ancestors. I suppose that 
being a ranger would mean a more active lifestyle and potentially better social circumstances 
including having employment and connections with people around them, so I would presume 
this has an impact on health too. Nevertheless, data presented shows that rangers actually 
had higher rates of smoking and alcohol use but still had better health than non-rangers.  
 
In this plenary a video talk was given by doctor Mark Wenitong who talked at length about the 
importance of recognising the work of aboriginal 'healers' as crucial for the health of these 
people. Though he was a medical doctor trained in the western method, he was of aboriginal 
descent and thus was able to see the importance of the healers through both the western and 
aboriginal lens. He insisted that the work of the healers was necessary as it took a more 
holistic approach to heath whereas western medicine concentrated on the reductionist 
method.  
 
I spent the afternoon in my choice of session. I chose to go to the table top presentations 
which consisted of researchers moving around the room to present to the people of the table. 
I was particularly interested by a piece of research into the abortion rates of different states 
and how there were huge increases in states which allowed abortion at their borders as 
women were crossing state lines to have access to abortion. It had been found that abortion 







The day 2 morning plenary was along the theme of climate change and its relation to public 
health. There was an emphasis placed on how public health officials have a role to play in the 
changing climate.  The first talk given by professor was enlightening and reminiscent of a TED 
talk in its style. it was enthusing to watch and listen to and I enjoyed observing the presentation 
of the data. Although it was realistic about the struggle humanity faced regarding climate 
change, there was a sense that we can still act and produce change if we act with rapidity.  
 
It was reflected that public health professionals had a duty to be part of government policy 
decisions due to the great impact that climate change is having and will have on human health. 
Particularly in those areas that are experiencing the greatest changes such as sea level rises, 
droughts and intense heat. This will obviously affect Australia therefore there is a consensus 
that change needs to happen fast.  
 
The talks easily took on a melancholy disposition but became more upbeat towards the end 
when it was elucidated the great amount of change already taking place in the renewable 
sectors and also the policy changed which are already being implemented.  
 
I spent the afternoon in a long presentation and then discussion given on falls and using 
exercise physiologists in care homes. I am unaware of the use of exercise physiologists in 
care homes in the UK. I would speculate that we do not use them as it is a novel approach in 
Australia. The care home using exercise physiologists were seeing excellent results and thus 
the speakers were hoping to widen the use of exercise physiologists in other care homes. 
 
Day 3.  
 
For the final day of the conference I was very privileged to have the opportunity to visit an 
indigenous community in North Queenslaand, the Yarrabah community. The trip to the 
Yarrabah community was an insightful look into how the determinants of health are being 
tackled by the local community.  
 
The trip focussed on learning about what health leaders were doing in the community to tackle 
the large disparities in health that the community faced. We were greeted by a local health 
contact and given an introduction by prominent leaders of the community who informed us of 
the main issues which they faced. In reality the issues were not dissimilar from those faced in 
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the Cwm Taf University Health Board including cardiovascular disease, high rates of obesity 
and diabetes and many of the associated social problems, drug dependency, alcoholism, 
gambling and crime. In contrast however, the rate of unemployment for the Yarrbah (60% 
unemployed) was significantly greater than for the residents of the Welsh Valleys (although 
they too have suffered from high levels of unemployment compared to the UK or even Welsh 
average).  
 
Although it may seem a large leap to be comparing an area of the incredibly influential and 
affluent United Kingdom to a community of indigenous people in Australia I would attest that 
the issues faced by these communities differ by degree but not by kind. In fact, from my 
reading and experience it is a similar story the world over. Populations that experience 
subjugating or exploitation at some point in their history take decades to recover and are still 
left behind economically. This turns once thriving communities into groups of people highly 
dependent on state government and it absolutely destroys their health. It is also highly 
degrading to the people concerned. Furthermore, it isn't very good for the country or 
population which took advantage in the first place as they then become destined to take care 
of a struggling population that cannot economically self-sustain or contribute much to the 
country they reside in. 
 
There are then parallels to the strife of the indigenous and those of the welsh valleys. Clearly 
both have been exploited, interestingly both exploited by the British and both in very recent 
history.  Also, of interest to me, and I think of relevance, is that both of these peoples have an 
extremely strong sense of identity, in that they identify passionately as a group and they rally 
around their culture. The welsh are famously patriotic and from what I saw of the indigenous 
people in Australia they are making great effort to safeguard their culture which they describe 
as being stolen from them. In fact, the 'stolen generation' is what this is partly referring to 
where aboriginal children were forcibly taken from their homes and made to assimilate into 
white culture.  Likewise, the welsh people were forced to speak English and forbidden from 
speaking their native language of Welsh.  
 
It seems clear to me that the parallels which exist between the poor areas of Wales and the 
aboriginal communities in Australia are largely due to inequality and thus the shared major 
social determinants of health. 
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See folder 
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See folder 
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9.8 S-PLAC survey 
Please see folder 
9.9 P-PLAC survey 












9.15 The KESS Programme 
 
The KESS 2 (Knowledge Economy Skills Scholarship) programme provided me with the 
opportunity to undertake a fully funded Master of Research programme. The programme is 
unique in academia due to its fundamental link between academia and industry. However, in 
the case of this specific project the link was with a public body.  
 
An aspect to the programme which I found to be very rewarding is its emphasis on developing 
oneself professional and thus using the programme as much as possible to this end. The 
KESS 2 ‘Grad School’, a three-day residential, provided the opportunity to network with other 
KESS candidates and to learn about the opportunities which are present outside of academia 
in the world of business or consulting.  
 
Whilst enrolled on this KESS programme I was also fortunate to be selected to attend a Welsh 
Government funded ‘Bootcamp to Business’ programme to expand my knowledge of business 
related skills. This was also a fantastic experience and tied in well with the overarching aims 
of the KESS programme. 
 
I enjoyed attending conferences whilst conducting my masters including a Public Health Wales 
Research and Development conference in Cardiff where I presented a poster. I was very 
fortunate to be granted funding by the Welsh European Funding Office to attend the Public 
Health Association of Australia annual national conference in Cairns, Australia in September 
2018. 
 
All in all, KESS enabled me to have a very productive and fulfilling year with ample funding for 
personal and professional development which would most likely have been unattainable on a 





9.16 KESS Disclaimer 
 
Knowledge Economy Skills Scholarships (KESS) is a pan-Wales higher level skills initiative 
led by Bangor University on behalf of the HE sector in Wales. It is part funded by the Welsh 
Government’s European Social Fund (ESF) convergence programme for West Wales and the 
Valleys.  
